Stocks
Profound Medical Corp.PROF
NASDAQHealthcareMedical Devices$5.51-0.72%
Develops and commercializes incision-free therapeutic systems for the ablation of diseased tissue, primarily in urology and oncology. Its flagship TULSA-PRO platform combines real-time MRI guidance with robotic transurethral ultrasound ablation, targeting prostate diseases. Investors monitor its progress as a potential disruptor in minimally invasive surgical alternatives.
Market Cap: $166.7M52W Range: $3.76 – $8.95
Congressional Interest in Profound Medical Corp. (PROF)
1 member of Congress has disclosed 4 trades in Profound Medical Corp. (PROF), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
1
Buys
4
Sells
0
Who in Congress Is Trading PROF?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-07-21 | Tom Malinowski | buy | $1K – $15K |
| 2020-01-27 | Tom Malinowski | buy | $1K – $15K |